Roads to Stat3 Paved with Cadherins

Area of Science:

• Cell Biology
• Molecular Biology
• Oncology

Background:

• Cadherins mediate cell-cell adhesion and influence intracellular signaling pathways.
• Signal transducer and activator of transcription-3 (Stat3) is a key regulator of cell division and survival.
• The interplay between cadherins, GTPases, and Stat3 in cellular processes is not fully understood.

Purpose of the Study:

• To elucidate the role of cadherin engagement in the activation of Stat3 signaling.
• To investigate the molecular mechanisms linking cadherins, Rac/Cdc42 GTPases, and IL6 family cytokines to Stat3.
• To explore the potential therapeutic implications of the cadherin-Stat3 axis in cancer.

Main Methods:

• Investigated the effect of cadherin engagement on Rac/Cdc42 GTPase activity and proteasomal degradation.
• Assessed the impact of cadherin signaling on IL6 family cytokine secretion and gp130 receptor activation.
• Analyzed Stat3 phosphorylation, dimerization, nuclear translocation, and target gene activation.
• Examined the role of Src oncogene and caveolin-1 in modulating the cadherin-Stat3 pathway.

Main Results:

• Cadherin engagement increases Rac/Cdc42 GTPase activity by inhibiting proteasomal degradation, leading to IL6 cytokine secretion and autocrine gp130 activation.
• This cascade results in Stat3 phosphorylation, dimerization, nuclear translocation, and activation of genes involved in cell division and survival.
• Src oncogene and caveolin-1 modulate this pathway, highlighting a critical balance between Src, cadherins, and gp130 for Stat3 activation.
• Absence of cadherin engagement leads to low Stat3 activity, emphasizing the importance of cadherin-gp130 interaction for Stat3 signaling.

Conclusions:

• Cadherin engagement is essential for Stat3 activation, primarily through the preservation of gp130 function and regulation of the Rac/gp130 axis.
• A delicate balance between Src, cadherins, and IL6 signaling is required for optimal Stat3 activation.
• The cadherin-Rac-gp130 pathway represents a conserved mechanism for Stat3 activation with significant implications for cancer biology and drug development.